DeDora Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DeDora Capital's NVO Position: Q3 2026 in Review
DeDora Capital opened a new position in Novo Nordisk (NVO) in Q3 2026: 599 shares worth $22.7K. The stake represents 0.01% of the portfolio and ranks #237 among its holdings. This is a return to the name: DeDora Capital previously reported a position in NVO as recently as Q1 2022.
DeDora Capital first reported a position in NVO in Q1 2022 and has held it in 2 quarters since. 1,227 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- DeDora Capital held 599 shares of Novo Nordisk worth $22.7K as of Q3 2026.
- Novo Nordisk was a new DeDora Capital position in Q3 2026.
- Novo Nordisk made up 0.01% of DeDora Capital's portfolio in Q3 2026, its #237 holding.
- DeDora Capital first reported a position in Novo Nordisk in Q1 2022 and has held it in 2 quarters since.
- 1,227 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.